NCT02360527View on ClinicalTrials.gov

Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Retinal NeurodegenerationAlzheimer´s DiseaseType 2 Diabetes
Trial Locations (1)

08035

Vall d´Hebron Research Institute VHIR, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT02360527 - Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease | Biotech Hunter | Biotech Hunter